How much is BioAge Labs worth in 2026?

BioAge Labs has a current valuation of N/A based on their Later Stage VC (Series D) round and secondary market data.

How much funding has BioAge Labs raised?

BioAge Labs has raised N/A in total funding across 2 funding rounds.

BioAge Labs

Drug Discovery

BioAge Labs valuation and funding history | Last updated: February 1, 2024 | 2 funding rounds

Current Valuation

N/A

As of February 1, 2024

Total Funding Raised

N/A

Across 2 rounds

Last Round

Later Stage VC (Series D)

$194.3M

Last Funding

Feb 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
February 1, 2024	Later Stage VC (Series D)	$194.3M	N/A	-
January 1, 2019	Accelerator/Incubator	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

BioAge Labs is currently valued at N/A as of February 1, 2024.

Track BioAge Labs Valuation Updates

Get notified when BioAge Labs raises new funding or valuation changes

Explore More Data

Detailed analysis for BioAge Labs

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock BioAge Labs's valuation history, funding rounds, and growth metrics.

No credit card required

What is BioAge Labs Worth in 2026?

BioAge Labs is a leading private company in the Drug Discovery sector. Track BioAge Labs's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How BioAge Labs Valuation is Determined

Private company valuations like BioAge Labs's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.